Science News
from research organizations

Implantable micro-device to monitor oxygen in glioma to improve treatment outcomes

Date:
May 21, 2015
Source:
Norris Cotton Cancer Center Dartmouth-Hitchcock Medical Center
Summary:
Monitoring oxygen levels in human tumors growing in a mouse brain using EPR oximetry with implantable resonators provides opportunities to evaluate and optimize various strategies being developed to improve oxygen levels in the glioma.
Share:
FULL STORY

A: Picture of the implantable resonator and placement in the brain to monitor contralateral brain (CLB) and glioma pO2. B: EPR signals acquired from the CLB and glioma using implantable resonators. Tissue pO2 (mmHg) is simultaneously monitored under baseline (anesthetized animals breathing 30% O2) and then carbogen (95% O2 + 5% CO2) inhalation. C. Geminin/Ki67 assay to assess cell cycle arrest in vivo.
Credit: Norris Cotton Cancer Center Shared Resources

Improving the level of oxygen in gliomas will have a proven positive affect on treatment outcomes. A team of investigators from Dartmouth's Norris Cotton Cancer Center led by Nadeem Khan, MSc, PhD has used electron paramagnetic resonance (EPR) technique to monitor the oxygen levels in the brain using implantable resonators. Their paper, titled "Monitoring oxygen levels in orthotopic human glioma xenograft following carbogen inhalation and chemotherapy by implantable resonator-based oximetry," was published recently in the International Journal of Cancer.

"For the first time, we were able to directly monitor oxygen levels in human tumors growing in a mouse brain using EPR oximetry with implantable resonators," explained Khan. "This provides exciting opportunities to evaluate and optimize various strategies being developed to improve oxygen levels in the glioma."

Treatment of glioma has remained a challenge despite the options for surgical resection followed by chemotherapy and radiotherapy. Hypoxia, very low levels of oxygen in glioma, plays a crucial role in resistance to radiotherapy because oxygen must be present for optimal fixation of DNA damage induced by ionizing radiation. Hypoxic cells are relatively resistant to radiotherapy, requiring up to three times the radiation dose as normal cells to result in the same level of cell killing. Despite the profound effect of hypoxia in compromising the effectiveness of radiotherapy, techniques to directly and repeatedly quantify oxygen levels in glioma in order to develop optimal hyperoxic strategies are lacking.

Khan's team set out to implement in vivo EPR oximetry using a method that employed implantable resonators for repeated measurement of oxygen levels in the glioma, and developed strategies to increase the levels to improve treatment outcomes. They have investigated temporal changes in oxygen levels of the normal brain and glioma in animal models subjected to breathing oxygen-enriched gases. They also investigated a new strategy to significantly inhibit glioma growth by rationally combining gemcitabine and MK-8776, a cell cycle checkpoint inhibitor.

"The treatment with gemcitabine and MK-8776 to inhibit glioma growth is a promising strategy that warrants further investigation," said Khan. "Real-time knowledge of oxygen levels in gliomas will be extremely useful in developing oxygen guided optimal treatment plans for each patient in the clinic."

The team is headed by Harold Swartz, MD, PhD, who is a leader in EPR technique and was recently awarded a five-year program project by National Cancer Institute (NCI) to investigate temporal changes in oxygen levels during tumor growth and treatment in patients. Together, these studies will provide essential evidence to inform therapies.

Collaborations such as these are common at Dartmouth's Norris Cotton Cancer Center, where team science is a top priority. Khan, an expert in oximetry from the Department of Radiology, collaborated with Alan Eastman, PhD, from the Department of Pharmacology & Toxicology, who brought expertise in the cell cycle. Huagang Hou, MD, Department of Radiology, contributed in the design and fabrication of the implantable resonators, and EPR measurements in this study.

Investigators at Dartmouth have extensive Shared Resources available for research and this team used the Pathology Shared Resource to evaluate cell cycle distribution in the glioma. These experiments were essential to understanding the effect of gemcitabine on cell cycle and the effective scheduling of checkpoint inhibitor for maximal malignant cell kill. The pre-clinical MRI Shared Resource was utilized to image glioma and monitor growth to determine treatment outcomes in this research.

Dartmouth's Shared Resources are also available to outside investigators by arrangement.

Looking forward, Khan's team plans to investigate treatment outcomes when radiotherapy is scheduled at times of an increase of oxygen levels in glioma. They will follow this approach to design a novel treatment plan by rationally combining gemcitabine with cell cycle checkpoint inhibitor, oxygen-enrich gas inhalation, and radiotherapy to significantly inhibit the growth of aggressive glioma.


Story Source:

Materials provided by Norris Cotton Cancer Center Dartmouth-Hitchcock Medical Center. Note: Content may be edited for style and length.


Journal Reference:

  1. Huagang Hou, Venkata Krishnamurthy Nemani, Gaixin Du, Ryan Montano, Rui Song, Barjor Gimi, Harold M. Swartz, Alan Eastman, Nadeem Khan. Monitoring oxygen levels in orthotopic human glioma xenograft following carbogen inhalation and chemotherapy by implantable resonator-based oximetry. International Journal of Cancer, 2015; 136 (7): 1688 DOI: 10.1002/ijc.29132

Cite This Page:

Norris Cotton Cancer Center Dartmouth-Hitchcock Medical Center. "Implantable micro-device to monitor oxygen in glioma to improve treatment outcomes." ScienceDaily. ScienceDaily, 21 May 2015. <www.sciencedaily.com/releases/2015/05/150521143819.htm>.
Norris Cotton Cancer Center Dartmouth-Hitchcock Medical Center. (2015, May 21). Implantable micro-device to monitor oxygen in glioma to improve treatment outcomes. ScienceDaily. Retrieved May 23, 2017 from www.sciencedaily.com/releases/2015/05/150521143819.htm
Norris Cotton Cancer Center Dartmouth-Hitchcock Medical Center. "Implantable micro-device to monitor oxygen in glioma to improve treatment outcomes." ScienceDaily. www.sciencedaily.com/releases/2015/05/150521143819.htm (accessed May 23, 2017).

RELATED STORIES